Innealta Capital’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,466
Closed -$35.9K 1125
2024
Q2
$35.9K Buy
+1,466
New +$35.9K 0.01% 448